terconazole vaginal cream 0.8%- terconazole cream
bryant ranch prepack - terconazole (unii: 0kj2ve664u) (terconazole - unii:0kj2ve664u) - terconazole vaginal cream 0.8% is indicated for the local treatment of vulvovaginal candidiasis (moniliasis). as terconazole vaginal cream 0.8% is effective only for vulvovaginitis caused by the genus candida, the diagnosis should be confirmed by koh smears and/or cultures. patients known to be hypersensitive to terconazole or to any of the components of the cream.
terconazole cream
remedyrepack inc. - terconazole (unii: 0kj2ve664u) (terconazole - unii:0kj2ve664u) - terconazole vaginal cream is indicated for the local treatment of vulvovaginal candidiasis (moniliasis). as terconazole vaginal cream is effective only for vulvovaginitis caused by the genus candida , the diagnosis should be confirmed by koh smears and/or cultures. patients known to be hypersensitive to terconazole or to any of the components of the cream.
terconazole cream
nucare pharmaceuticals,inc. - terconazole (unii: 0kj2ve664u) (terconazole - unii:0kj2ve664u) - terconazole vaginal cream is indicated for the local treatment of vulvovaginal candidiasis (moniliasis). as terconazole vaginal cream is effective only for vulvovaginitis caused by the genus candida , the diagnosis should be confirmed by koh smears and/or cultures. patients known to be hypersensitive to terconazole or to any of the components of the cream.
terconazole cream
rebel distributors corp - terconazole (unii: 0kj2ve664u) (terconazole - unii:0kj2ve664u) - terconazole vaginal cream 0.4% is indicated for the local treatment of vulvovaginal candidiasis (moniliasis). as terconazole vaginal cream 0.4% is effective only for vulvovaginitis caused by the genus candida , the diagnosis should be confirmed by koh smears and/or cultures. patients known to be hypersensitive to terconazole or to any of the components of the cream.
taro-terconazole cream
taro pharmaceuticals inc - terconazole - cream - 0.4% - terconazole 0.4% - azoles
terconazole vaginal cream 0.8%- terconazole cream
a-s medication solutions - terconazole (unii: 0kj2ve664u) (terconazole - unii:0kj2ve664u) - terconazole vaginal cream 0.8% is indicated for the local treatment of vulvovaginal candidiasis (moniliasis). as terconazole vaginal cream 0.8% is effective only for vulvovaginitis caused by the genus candida, the diagnosis should be confirmed by koh smears and/or cultures. patients known to be hypersensitive to terconazole or to any of the components of the cream.
terconazole cream
taro pharmaceuticals u.s.a., inc. - terconazole (unii: 0kj2ve664u) (terconazole - unii:0kj2ve664u) - terconazole vaginal cream is indicated for the local treatment of vulvovaginal candidiasis (moniliasis). as terconazole vaginal cream is effective only for vulvovaginitis caused by the genus candida , the diagnosis should be confirmed by koh smears and/or cultures. patients known to be hypersensitive to terconazole or to any of the components of the cream.
terconazole cream
taro pharmaceuticals u.s.a., inc. - terconazole (unii: 0kj2ve664u) (terconazole - unii:0kj2ve664u) - terconazole vaginal cream is indicated for the local treatment of vulvovaginal candidiasis (moniliasis). as terconazole vaginal cream is effective only for vulvovaginitis caused by the genus candida , the diagnosis should be confirmed by koh smears and/or cultures. patients known to be hypersensitive to terconazole or to any of the components of the cream.
terconazole suppository
taro pharmaceuticals u.s.a., inc. - terconazole (unii: 0kj2ve664u) (terconazole - unii:0kj2ve664u) - terconazole vaginal suppositories, 80 mg is indicated for the local treatment of vulvovaginal candidiasis (moniliasis). as this product is effective only for vulvovaginitis caused by the genus candida , the diagnosis should be confirmed by koh smears and/or cultures. patients known to be hypersensitive to terconazole or to any of the components of the suppositories.
terazol® 7 vaginal cream 0.4% (terconazole) terazol® 3 vaginal cream 0.8% (terconazole) terazol® 3 vagina
janssen pharmaceuticals, inc. - terconazole (unii: 0kj2ve664u) (terconazole - unii:0kj2ve664u) - terconazole 4 mg in 1 g - terazol® 7 (terconazole) vaginal cream 0.4%, terazol® 3 (terconazole) vaginal cream 0.8% and terazol® 3 (terconazole) vaginal suppositories 80 mg are indicated for the local treatment of vulvovaginal candidiasis (moniliasis). as these products are effective only for vulvovaginitis caused by the genus candida, the diagnosis should be confirmed by koh smears and/or cultures. patients known to be hypersensitive to terconazole or to any of the components of the cream or suppositories.